Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells

Journal of Cell Biology

Volumn 178, Issue 1, 2007, Pages 93-105

  Yuneva, Mariia ^a,b   Zamboni, Nicola ^c   Oefner, Peter ^d   Sachidanandam, Ravi ^a   Lazebnik, Yuri ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ETH ZURICH   (Switzerland)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; GLUTAMINE; MYC PROTEIN;

AMINO ACID DEFICIENCY; APOPTOSIS; ARTICLE; CANCER CELL; CITRIC ACID CYCLE; CONTROLLED STUDY; DEPLETION; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN MALNUTRITION; PROTEIN SYNTHESIS; STARVATION;

APOPTOSIS; CELL CULTURE TECHNIQUES; CELL LINE; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION REGULATION; GLUCOSE; GLUTAMINE; HUMANS; LUNG; MALE; PROTO-ONCOGENE PROTEINS C-MYC; RETROVIRIDAE; SKIN; TRANSDUCTION, GENETIC;

RODENTIA;

EID: 34347402459     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200703099     Document Type: Article

References (71)

1. Adhikary, S., and M. Eilers. 2005. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 6:635-645.
2. Ahluwalia, G.S., J.L. Grem, Z. Hao, and D.A. Cooney. 1990. Metabolism and action of amino acid analog anti-cancer agents. Pharmacol. Ther. 46:243-271.
3. Albayrak, T., V. Scherhammer, N. Schoenfeld, E. Braziulis, T. Mund, M.K. Bauer, I.E. Scheffler, and S. Grimm. 2003. The tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis induction. Mol. Biol. Cell. 14:3082-3096.
4. Anderson, C.P., J. Tsai, W. Chan, C.K. Park, L. Tian, R.M. Lui, H.J. Forman, and C.P. Reynolds. 1997. Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines. Eur. J. Cancer. 33:2016-2019.
5. Baggetto, L.G. 1992. Deviant energetic metabolism of glycolytic cancer cells. Biochimie. 74:959-974.
6. Benassi, B., M. Fanciulli, F. Fiorentino, A. Porrello, G. Chiorino, M. Loda, G. Zupi, and A. Biroccio. 2006. c-Myc phosphorylation is required for cellular response to oxidative stress. Mol. Cell. 21:509-519.
7. Bergmeyer, H.U. 1974. Lactate dehydrogenase assay with pyruvate and NADH. In Methods of Enzymatic Analysis. Vol. 2. H.U. Bergmeyer, editor. Academic Press, New York. pp. 574-579.
8. Bode, B.P., B.C. Fuchs, B.P. Hurley, J.L. Conroy, J.E. Suetterlin, K.K. Tanabe, D.B. Rhoads, S.F. Abcouwer, and W.W. Souba. 2002. Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells. Am. J. Physiol. Gastrointest. Liver Physiol. 283:G1062-G1073.
9. Chen, Z., J. Zang, J. Whetstine, X. Hong, F. Davrazou, T.G. Kutateladze, M. Simpson, Q. Mao, C.H. Pan, S. Dai, et al. 2006. Structural insights into histone demethylation by JMJD2 family members. Cell. 125:691-702.
10. Curi, R., C.J. Lagranha, S.Q. Doi, D.F. Sellitti, J. Procopio, T.C. Pithon-Curi, M. Corless, and P. Newsholme. 2005. Molecular mechanisms of glutamine action. J. Cell. Physiol. 204:392-401.
11. Egle, A., A.W. Harris, P. Bouillet, and S. Cory. 2004. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc. Natl. Acad. Sci. USA. 101:6164-6169.
12. Eilers, M., D. Picard, K.R. Yamamoto, and J.M. Bishop. 1989. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature. 340:66-68.
13. Enari, M., H. Hug, and S. Nagata. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature. 375:78-81.
14. Faleiro, L., and Y. Lazebnik. 2000. Caspases disrupt the nuclear-cytoplasmic barrier. J. Cell Biol. 151:951-959.
15. Fearnhead, H.O., J. Rodriguez, E.E. Govek, W. Guo, R. Kobayashi, G. Hannon, and Y.A. Lazebnik. 1998. Oncogene-dependent apoptosis is mediated by caspase-9. Proc. Natl. Acad. Sci. USA. 95:13664-13669.
16. Fuchs, B.C., and B.P. Bode. 2006. Stressing out over survival: glutamine as an apoptotic modulator. J. Surg. Res. 131:26-40.
17. Fulda, S., and K.M. Debatin. 2007. HIF-1-regulated glucose metabolism: a key to apoptosis resistance? Cell Cycle. 6:790-792.
18. Garber, K. 2006. Energy deregulation: licensing tumors to grow. Science. 312:1158-1159.
19. Green, D.R., and G. Kroemer. 2004. The pathophysiology of mitochondrial cell death. Science. 305:626-629.
20. Griffith, O.W., and A. Meister. 1979. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J. Biol. Chem. 254:7558-7560.
21. Guerin, P.J., T. Furtak, K. Eng, and E.R. Gauthier. 2006. Oxidative stress is not required for the induction of apoptosis upon glutamine starvation of Sp2/0-Ag14 hybridoma cells. Eur. J. Cell Biol. 85:355-365.
22. Hammerman, P.S., C.J. Fox, and C.B. Thompson. 2004. Beginnings of a signal-transduction pathway for bioenergetic control of cell survival. Trends Biochem. Sci. 29:586-592.
23. Hannon, G.J., P. Sun, A. Carnero, L.Y. Xie, R. Maestro, D.S. Conklin, and D. Beach. 1999. MaRX: an approach to genetics in mammalian cells. Science. 283:1129-1130.
24. Holcik, M., and N. Sonenberg. 2005. Translational control in stress and apoptosis. Nat. Rev. Mol. Cell Biol. 6:318-327.
25. Izyumov, D.S., A.V. Avetisyan, O.Y. Pletjushkina, D.V. Sakharov, K.W. Wirtz, B.V. Chernyak, and V.P. Skulachev. 2004. "Wages of fear": transient threefold decrease in intracellular ATP level imposes apoptosis. Biochim. Biophys. Acta. 1658:141-147.
26. Jonas, E.A., J.A. Hickman, M. Chachar, B.M. Polster, T.A. Brandt, Y. Fannjiang, I. Ivanovska, G. Basanez, K.W. Kinnally, J. Zimmerberg, et al. 2004. Proapoptotic N-truncated BCL-xL protein activates endogenous mitochondrial channels in living synaptic terminals. Proc. Natl. Acad. Sci. USA. 101:13590-13595.
27. Knox, W.E., M.L. Horowitz, and G.H. Friedell. 1969. The proportionality of glutaminase content to growth rate and morphology of rat neoplasms. Cancer Res. 29:669-680.
28. Kovacevic, Z. 1972. Possibility for the transfer of reducing equivalents from the cytosol to the mitochondrial compartment in Ehrlich ascites tumor cells by the malate-aspartate shuttle. Eur. J. Biochem. 25:372-378.
29. Kovacevic, Z., O. Brkljac, and K. Bajin. 1991. Control and function of the transamination pathways of glutamine oxidation in tumour cells. Biochem. J. 273:271-275.
30. Ladurner, A.G. 2006. Rheostat control of gene expression by metabolites. Mol. Cell. 24:1-11.
31. Le Belle, J.E., N.G. Harris, S.R. Williams, and K.K. Bhakoo. 2002. A comparison of cell and tissue extraction techniques using high-resolution 1H-NMR spectroscopy. NMR Biomed. 15:37-44.
32. Li, F., Y. Wang, K.I. Zeller, J.J. Potter, D.R. Wonsey, K.A. O'Donnell, J.W. Kim, J.T. Yustein, L.A. Lee, and C.V. Dang. 2005. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol. Cell. Biol. 25:6225-6234.
33. Linder-Horowitz, M., W.E. Knox, and H.P. Morris. 1969. Glutaminase activities and growth rates of rat hepatomas. Cancer Res. 29:1195-1199.
34. Linker, W., M. Loffler, and F. Schneider. 1985. Uridine, but not cytidine can sustain growth of Ehrlich ascites tumor cells in glucose-deprived medium with altered proliferation kinetics. Eur. J. Cell Biol. 36:176-181.
35. Littlewood, T.D., D.C. Hancock, P.S. Danielian, M.G. Parker, and G.I. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686-1690.
36. Lowry, O.H., J.V. Passonneau, D.W. Schulz, and M.K. Rock. 1961. The measurement of pyridine nucleotides by enzymatic cycling. J. Biol. Chem. 236:2746-2755.
37. Maclean, K.H., U.B. Keller, C. Rodriguez-Galindo, J.A. Nilsson, and J.L. Cleveland. 2003. c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL. Mol. Cell. Biol. 23:7256-7270.
38. Medina, M.A. 2001. Glutamine and cancer. J. Nutr. 131:2539S-2542S (discussion 2550S-1S).
39. Moreadith, R.W., and A.L. Lehninger. 1984. The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme. J. Biol. Chem. 259:6215-6221.
40. Morrish, F., C. Giedt, and D. Hockenbery. 2003. c-MYC apoptotic function is mediated by NRF-1 target genes. Genes Dev. 17:240-255.
41. Nath, K.A., E.O. Ngo, R.P. Hebbel, A.J. Croatt, B. Zhou, and L.M. Nutter. 1995. alpha-Ketoacids scavenge H2O2 in vitro and in vivo and reduce menadione-induced DNA injury and cytotoxicity. Am. J. Physiol. 268:C227-C236.
42. Nesbit, C.E., J.M. Tersak, and E.V. Prochownik. 1999. MYC oncogenes and human neoplastic disease. Oncogene. 18:3004-3016.
43. Newsholme, E.A., B. Crabtree, and M.S. Ardawi. 1985. The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells. Biosci. Rep. 5:393-400.
44. O'Connell, B.C., A.F. Cheung, C.P. Simkevich, W. Tam, X. Ren, M.K. Mateyak, and J.M. Sedivy. 2003. A large scale genetic analysis of c-Myc-regulated gene expression patterns. J. Biol. Chem. 278:12563-12573.
45. O'Donnell-Tormey, J., C.F. Nathan, K. Lanks, C.J. DeBoer, and J. de la Harpe. 1987. Secretion of pyruvate. An antioxidant defense of mammalian cells. J. Exp. Med. 165:500-514.
46. Osthus, R.C., H. Shim, S. Kim, Q. Li, R. Reddy, M. Mukherjee, Y. Xu, D. Wonsey, L.A. Lee, and C.V. Dang. 2000. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J. Biol. Chem. 275:21797-21800.
47. Panosyan, E.H., R.S. Grigoryan, I.A. Avramis, N.L. Seibel, P.S. Gaynon, S.E. Siegel, H.J. Fingert, and V.I. Avramis. 2004. Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961). Anticancer Res. 24:1121-1125.
48. Pelengaris, S., and M. Khan. 2003. The many faces of c-MYC. Arch. Biochem. Biophys. 416:129-136.
49. Perez-Gomez, C., J.A. Campos-Sandoval, F.J. Alonso, J.A. Segura, E. Manzanares, P. Ruiz-Sanchez, M.E. Gonzalez, J. Marquez, and J.M. Mates. 2005. Co-expression of glutaminase K and L isoenzymes in human tumour cells. Biochem. J. 386:535-542.
50. Petch, D., and M. Butler. 1994. Profile of energy metabolism in a murine hybridoma: glucose and glutamine utilization. J. Cell. Physiol. 161:71-76.
51. Ramanathan, A., C. Wang, and S.L. Schreiber. 2005. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc. Natl. Acad. Sci. USA. 102:5992-5997.
52. Reitzer, L.J., B.M. Wice, and D. Kennell. 1979. Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J. Biol. Chem. 254:2669-2676.
53. Rogakou, E.P., D.R. Pilch, A.H. Orr, V.S. Ivanova, and W.M. Bonner. 1998. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273:5858-5868.
54. Rohren, E.M., T.G. Turkington, and R.E. Coleman. 2004. Clinical applications of PET in oncology. Radiology. 231:305-332.
55. Sabatini, D.M. 2006. mTOR and cancer: insights into a complex relationship. Nat. Rev. Cancer. 6:729-734.
56. Selak, M.A., S.M. Armour, E.D. MacKenzie, H. Boulahbel, D.G. Watson, K.D. Mansfield, Y. Pan, M.C. Simon, C.B. Thompson, and E. Gottlieb. 2005. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell. 7:77-85.
57. Sen, C.K., S. Roy, and L. Packer. 1999. Flow cytometric determination of cellular thiols. Methods Enzymol. 299:247-258.
58. Shaw, R.J., and L.C. Cantley. 2006. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature. 441:424-430.
59. Shaw, R.J., N. Bardeesy, B.D. Manning, L. Lopez, M. Kosmatka, R.A. DePinho, and L.C. Cantley. 2004. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell. 6:91-99.
60. Shim, H., Y.S. Chun, B.C. Lewis, and C.V. Dang. 1998. A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc. Natl. Acad. Sci. USA. 95:1511-1516.
61. Soga, T., Y. Ohashi, Y. Ueno, H. Naraoka, M. Tomita, and T. Nishioka. 2003. Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J. Proteome Res. 2:488-494.
62. Stet, E.H., R.A. De Abreu, J.P. Bokkerink, L.H. Lambooy, T.M. Vogels-Mentink, J.J. Keizer-Garritsen, and F.J. Trijbels. 1995. Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenine. Biochem. Pharmacol. 49:49-56.
63. Thompson, C.B., D.E. Bauer, J.J. Lum, G. Hatzivassiliou, W.X. Zong, F. Zhao, D. Ditsworth, M. Buzzai, and T. Lindsten. 2005. How do cancer cells acquire the fuel needed to support cell growth? Cold Spring Harb. Symp. Quant. Biol. 70:357-362.
64. Vafa, O., M. Wade, S. Kern, M. Beeche, T.K. Pandita, G.M. Hampton, and G.M. Wahl. 2002. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol. Cell. 9:1031-1044.
65. Warburg, O. 1956. On the origin of cancer cells. Science. 123:309-314.
66. Wice, B.M., L.J. Reitzer, and D. Kennell. 1981. The continuous growth of vertebrate cells in the absence of sugar. J. Biol. Chem. 256:7812-7819.
67. Yang, N.C., W.M. Ho, Y.H. Chen, and M.L. Hu. 2002. A convenient one-step extraction of cellular ATP using boiling water for the luciferin-luciferase assay of ATP. Anal. Biochem. 306:323-327.
68. Zhou, W., P.J. Simpson, J.M. McFadden, C.A. Townsend, S.M. Medghalchi, A. Vadlamudi, M.L. Pinn, G.V. Ronnett, and F.P. Kuhajda. 2003. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. Cancer Res. 63:7330-7337.
69. Zielke, H.R., C.M. Sumbilla, D.A. Sevdalian, R.L. Hawkins, and P.T. Ozand. 1980. Lactate: a major product of glutamine metabolism by human diploid fibroblasts. J. Cell. Physiol. 104:433-441.
70. Zielke, H.R., C.L. Zielke, and P.T. Ozand. 1984. Glutamine: a major energy source for cultured mammalian cells. Fed. Proc. 43:121-125.
71. Zu, X.L., and M. Guppy. 2004. Cancer metabolism: facts, fantasy, and fiction. Biochem. Biophys. Res. Commun. 313:459-465.